Thrivent Financial for Lutherans Buys 393,970 Shares of STERIS plc $STE

Thrivent Financial for Lutherans boosted its stake in STERIS plc (NYSE:STE) by 246.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 553,834 shares of the medical equipment provider’s stock after acquiring an additional 393,970 shares during the quarter. Thrivent Financial for Lutherans owned 0.56% of STERIS worth $137,041,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in STERIS in the second quarter valued at $289,132,000. Orbis Allan Gray Ltd boosted its stake in shares of STERIS by 36.0% during the 2nd quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after buying an additional 556,088 shares during the last quarter. Invesco Ltd. grew its holdings in shares of STERIS by 32.2% in the 2nd quarter. Invesco Ltd. now owns 1,220,699 shares of the medical equipment provider’s stock valued at $293,236,000 after acquiring an additional 297,076 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of STERIS by 305.9% in the third quarter. Assenagon Asset Management S.A. now owns 330,907 shares of the medical equipment provider’s stock valued at $81,880,000 after acquiring an additional 249,386 shares during the last quarter. Finally, Qube Research & Technologies Ltd bought a new stake in STERIS during the second quarter worth about $58,402,000. Institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In other STERIS news, VP Renato Tamaro sold 5,036 shares of the stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president directly owned 5,695 shares of the company’s stock, valued at approximately $1,466,747.25. This represents a 46.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Julia Madsen sold 5,008 shares of the stock in a transaction on Friday, November 21st. The stock was sold at an average price of $262.00, for a total value of $1,312,096.00. Following the transaction, the vice president owned 10,710 shares of the company’s stock, valued at $2,806,020. The trade was a 31.86% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 25,044 shares of company stock worth $6,586,218 in the last ninety days. Company insiders own 1.07% of the company’s stock.

STERIS Trading Up 0.4%

STE stock opened at $262.81 on Friday. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44. The company has a market capitalization of $25.79 billion, a PE ratio of 37.76 and a beta of 1.03. The company’s 50-day simple moving average is $259.30 and its 200 day simple moving average is $248.75. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.09. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a return on equity of 14.43% and a net margin of 12.07%.During the same period in the previous year, the business earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, sell-side analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be given a dividend of $0.63 per share. The ex-dividend date of this dividend is Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. STERIS’s dividend payout ratio (DPR) is currently 36.21%.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $273.50.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.